We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Various Factors Influence Cardiac Troponin Concentrations

By LabMedica International staff writers
Posted on 14 Sep 2017
Print article
Image: The ARCHITECT i2000SR immunoassay analyzer (Photo courtesy of Abbott Laboratories).
Image: The ARCHITECT i2000SR immunoassay analyzer (Photo courtesy of Abbott Laboratories).
Cardiovascular diseases are the second most common cause of death in Japan, and the number of new cases is continuously growing. Among the cardiovascular diseases, one-third is attributed to ischemic heart diseases including acute myocardial infarction (AMI).

Cardiac troponin I is a protein that is specifically expressed in cardiomyocytes and is eluted in the blood when cardiomyocytes are injured such as by ischemia. Due to its specificity, cardiac troponin I has become one of the most reliable biomarkers for the diagnosis of AMI.

Scientists at the Japanese Red Cross Medical Center (Tokyo, Japan) and their colleagues enrolled a total of 698 apparently healthy individuals (385 females and 313 males) between the ages of 23 and 86 who visited the Medical Center for a health checkup from January through April in 2014 were included in this study.

The team performed routine biochemistry tests on a BioMajesty JCA-BM6070 clinical biochemistry analyzer that included the assays for aspartate aminotransferase (AST), alanine aminotransferase (ALT), gamma glutamyl transferase (GGT), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), creatinine (Cre), hemoglobin A1c (HbA1c), and lactate dehydrogenase (LDH). Serum samples were used for the measurement of all the assays except for HbA1c, which was measured with whole-blood samples.

The Abbott Laboratories’ STAT high-sensitive troponin I (hsTnI) was performed for the measurement of cardiac troponin I on Architect i2000. The limit of detection (LoD) of the assay was 1.9 pg/mL, the lowest concentration where 10% coefficient of variation (CV) was supported was 4.7 pg/mL and the overall 99th percentile was 26.2 pg/mL. The CardioPhase high-sensitive C-reactive protein (hsCRP) tests were performed for the measurement of CRP. The limit of detection (LoD) of the assay was 0.175 mg/L, the CV was 7.6% at 0.410 mg/L and the reference value was 3 mg/L.

The scientists found that the 99th percentile of the hsTnI in the overall population was 22.5 pg/mL, 17.7 pg/mL for females and 30.6 pg/mL for males. The median of the hsTnI in the overall population was 3.2 pg/mL, 2.6 pg/mL for females and 4.0 pg/mL for males. The age and gender had a significant influence on these values. The troponin I level also showed significant associations with the body mass index (BMI), the gamma glutamyl transferase (GGT), lactate dehydrogenase (LDH), estimated glomerular filtration rate (eGFR), and cardiac abnormalities by electrocardiography (ECG), but not with the high-sensitive C-reactive protein (hsCRP) level.

The authors concluded that the 99th percentiles of the troponin I measured in the general population in Japan were comparable as the ones derived in the USA, Germany, and Singapore. The troponin I level was dependent on the gender, age, BMI, and cardiac abnormalities found by electrocardiogram (ECG) but not by the hsCRP level. The study was published on August 1, 2017, in the Journal of Clinical Laboratory Analysis.

Related Links:
Japanese Red Cross Medical Center

Gold Member
Chagas Disease Test
CHAGAS Cassette
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Biological Indicator Vials
BI-O.K.
New
Uric Acid and Blood Glucose Meter
URIT-10

Print article

Channels

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Pathology

view channel
Image: The ready-to-use DUB enzyme assay kits accelerate routine DUB activity assays without compromising data quality (Photo courtesy of Adobe Stock)

Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation

Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.